Document Detail


Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke.
MedLine Citation:
PMID:  20955426     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Stroke induces a complex web of pathophysiology that may evolve over hours to days and weeks after onset. It is now recognized that inflammation is an important phenomenon that can dramatically influence outcomes after stroke. In this minireview, we explore the hypothesis that inflammatory signals after stroke are biphasic in nature. The high-mobility group box 1 (HMGB1) protein is discussed as an example of this idea. HMGB1 is normally present in the nucleus. Under ischemic conditions, it is released extracellularly from many types of cells. During the acute phase poststroke, HMGB1 promotes necrosis and influx of damaging inflammatory cells. However, during the delayed phase poststroke, HMGB1 can mediate beneficial plasticity and recovery in many cells of the neurovascular unit. These emerging findings support the hypothesis that inflammation after stroke can be both detrimental and beneficial, depending on the cellular situations involved.
Authors:
Kazuhide Hayakawa; Jianhua Qiu; Eng H Lo
Related Documents :
20571256 - Gene expression profiling of apoptosis regulators in patients with sepsis.
21777656 - P38β mapk affords cytoprotection against oxidative stress-induced astrocyte apoptosis ...
18714026 - Splenectomy protects against sepsis lethality and reduces serum hmgb1 levels.
19864946 - Effects of sepsis on neutrophil chemotaxis.
21593476 - The role of autophagy in corpus luteum regression in the rat.
3541546 - Natural history of the obstructed rabbit appendix: observations with radiography, sonog...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  1207     ISSN:  1749-6632     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-19     Completed Date:  2010-11-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  50-7     Citation Subset:  IM    
Copyright Information:
© 2010 New York Academy of Sciences.
Affiliation:
Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA. khayakawa1@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Extracellular Space / physiology
HMGB1 Protein / physiology*
Humans
Inflammation / physiopathology*
Models, Neurological
Receptors, Immunologic / physiology
Signal Transduction / physiology
Stroke / physiopathology*
Toll-Like Receptor 4 / physiology
Chemical
Reg. No./Substance:
0/HMGB1 Protein; 0/Receptors, Immunologic; 0/Toll-Like Receptor 4; 0/advanced glycosylation end-product receptor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The neurovascular unit, matrix proteases, and innate inflammation.
Next Document:  Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, an...